Taken together, our results demonstrate VSIG4-H3K18la-SPP1 signaling, beyond the checkpoint function of VSIG4 directly inhibiting T cells, confers on TAMs an emerging way to foster the immunosuppressive microenvironment and impair antigen-specific immunity against aggressive cancers. The gene discussed is VSIG4; the disease is cancer.